An Escherichia coli O157-Specific Engineered Pyocin Prevents and Ameliorates Infection by E. coli O157:H7 in an Animal Model of Diarrheal Disease

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Antimicrobial Agents and Chemotherapy

• Publication date

  2011-09-26

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1128/AAC.05031-11PMID 21947394PMCID PMC3232761
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Microencapsulation of budesonide with dextran by spray drying technique for colon-targeted delivery: an in vitro/in vivo evaluation in induced colitis in rat

  2011cited by this paper
• Antimicrobial and antimotility agent use in persons with shiga toxin-producing Escherichia coli O157 infection in FoodNet Sites.

  2011cited by this paper
• Escherichia coli O157

  2010cited by this paper
• Distinct Physiologic and Inflammatory Responses Elicited in Baboons after Challenge with Shiga Toxin Type 1 or 2 from Enterohemorrhagic Escherichia coli

  2010cited by this paper
• Escherichia coli O157

  2009cited by this paper
• An Engineered R-Type Pyocin Is a Highly Specific and Sensitive Bactericidal Agent for the Food-Borne Pathogen Escherichia coli O157:H7

  2009cited by this paper
• Type 2 Secretion Promotes Enterohemorrhagic Escherichia coli Adherence and Intestinal Colonization

  2008cited by this paper
• Antibacterial Efficacy of R-Type Pyocins towards Pseudomonas aeruginosa in a Murine Peritonitis Model

  2008cited by this paper
• Mouse Model of Hemolytic-Uremic Syndrome Caused by Endotoxin-Free Shiga Toxin 2 (Stx2) and Protection from Lethal Outcome by Anti-Stx2 Antibody

  2008cited by this paper
• Retargeting R-Type Pyocins To Generate Novel Bactericidal Protein Complexes

  2008cited by this paper
• Renal damage and death in weaned mice after oral infection with Shiga toxin 2‐producing Escherichia coli strains

  2008cited by this paper
• Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome.

  2005cited by this paper
• Critical Roles for stx2,eae, and tir in EnterohemorrhagicEscherichia coli-Induced Diarrhea and Intestinal Inflammation in Infant Rabbits

  2003influential reference
• Response to Shiga toxin 1 and 2 in a baboon model of hemolytic uremic syndrome

  2003cited by this paper
• The pyocins of Pseudomonas aeruginosa.

  2002cited by this paper
• Quinolone antibiotics induce Shiga toxin-encoding bacteriophages, toxin production, and death in mice.

  2000influential reference
• The risk of the hemolytic-uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 infections.

  2000influential reference
• The R‐type pyocin of Pseudomonas aeruginosa is related to P2 phage, and the F‐type is related to lambda phage

  2000cited by this paper
• Escherichia coli O157:H7

  1998cited by this paper
• Escherichia coli O157:H7.

  1995cited by this paper
• Role of Shiga-like toxin I in bacterial enteritis: comparison between isogenic Escherichia coli strains induced in rabbits.

  1994cited by this paper
• A model of food-borne Listeria monocytogenes infection in the Sprague-Dawley rat using gastric inoculation: development and effect of gastric acidity on infective dose.

  1993cited by this paper
• Experimental verocytotoxemia in rabbits

  1992cited by this paper
• Shiga toxin: biochemistry, genetics, mode of action, and role in pathogenesis.

  1992cited by this paper
• Pyocin R1 inhibits active transport in Pseudomonas aeruginosa and depolarizes membrane potential

  1984cited by this paper
• Hemorrhagic colitis associated with a rare Escherichia coli serotype.

  1983cited by this paper
• Defective pyocin particles produced by some mutant strains of Pseudomonas aeruginosa

  1975cited by this paper
• Protective effect of pyocin against lethal Pseudomonas aeruginosa infections in mice.

  1974cited by this paper
• Use of pyocin 78-C2 in the treatment of Pseudomonas aeruginosa infection in mice.

  1972cited by this paper

• Extracellular contractile injection systems for high efficiency protein delivery to plants

  2025cites this paper
• Novel Receptor Binding Domains Fused to the R2 Pyocin Tail Fiber Kill Target Bacteria

  2025influential citation
• Molecular farming for sustainable production of clinical‐grade antimicrobial peptides

  2024cites this paper
• A VersaTile Approach to Reprogram the Specificity of the R2-Type Tailocin Towards Different Serotypes of Escherichia coli and Klebsiella pneumoniae

  2024cites this paper
• Schistosomiasis–Microbiota Interactions: A Systematic Review and Meta-Analysis

  2024cites this paper
• Campycins are novel broad-spectrum antibacterials killing Campylobacter jejuni

  2023cites this paper
• Evolutionary and ecological role of extracellular contractile injection systems: from threat to weapon

  2023cites this paper
• F-Type Pyocins Are Diverse Noncontractile Phage Tail-Like Weapons for Killing Pseudomonas aeruginosa

  2023cites this paper
• Phage-tail-like bacteriocins as a biomedical platform to counter anti-microbial resistant pathogens.

  2022cites this paper
• The In Vivo and In Vitro Assessment of Pyocins in Treating Pseudomonas aeruginosa Infections

  2022cites this paper
• Enzybiotics: Endolysins and Bacteriocins

  2021cites this paper
• Recombinant R2-pyocin cream is effective in treating Pseudomonas aeruginosa-infected wounds.

  2021cites this paper
• Quantitative description of a contractile macromolecular machine

  2021cites this paper
• Reprogramming bacteriophage host range: design principles and strategies for engineering receptor binding proteins.

  2021cites this paper
• Infant Rabbit Model for Studying Shiga Toxin-Producing Escherichia coli.

  2021cites this paper
• Systematic discovery of pseudomonad genetic factors involved in sensitivity to tailocins

  2020cites this paper
• Antibacterial efficacy of R-type pyocins against Pseudomonas aeruginosa on biofilms and in a murine model of acute lung infection.

  2020cites this paper
• Prophylactic Application of Tailocins Prevents Infection by Pseudomonas syringae

  2020cites this paper
• Treatment Strategies for Infections With Shiga Toxin-Producing Escherichia coli

  2020cites this paper
• Pseudomonas Can Survive Tailocin Killing via Persistence-Like and Heterogenous Resistance Mechanisms

  2020cites this paper
• Action of a minimal contractile bactericidal nanomachine

  2020cites this paper
• Pseudomonas can survive bacteriocin-mediated killing via a persistence-like mechanism

  2019cites this paper
• A nanobody targeting the translocated intimin receptor inhibits the attachment of enterohemorrhagic E. coli to human colonic mucosa

  2019cites this paper
• Evidence of Tailocin Persistence and Resistance in Pseudomonas

  2019cites this paper
• Gut Microbiota and Colonization Resistance against Bacterial Enteric Infection

  2019cites this paper
• R pyocin tail fiber structure reveals a receptor-binding domain with a lectin fold

  2019cites this paper
• Engineering of receptor-binding proteins in bacteriophages and phage tail-like bacteriocins.

  2019cites this paper
• Phage-Derived Antibacterials: Harnessing the Simplicity, Plasticity, and Diversity of Phages

  2019cites this paper
• Structure of N-truncated R1-type pyocin tail fiber at 1.7 angstrom resolution

  2019cites this paper
• Crystal structure of the R-type bacteriocin tube protein CD1364 from Clostridium difficile in the pre-assembled state

  2018cites this paper
• Commensurability between protein nanotubes in contractile ejection nanomachines.

  2018cites this paper
• Antibacterial Weapons: Targeted Destruction in the Microbiota.

  2018cites this paper
• Crystal Structures of R-Type Bacteriocin Sheath and Tube Proteins CD1363 and CD1364 From Clostridium difficile in the Pre-assembled State

  2018cites this paper
• Susceptibility to R-pyocins of Pseudomonas aeruginosa clinical isolates from cystic fibrosis patients

  2018cites this paper
• Avaliação da atividade bactericida da piocina S8 contra cepas de Pseudomonas aeruginosa multirresistentes.

  2017cites this paper
• Effect of a Pseudomonas fluorescens tailocin against phytopathogenic Xanthomonas observed by atomic force microscopy.

  2017cites this paper
• Using Force to Punch Holes: Mechanics of Contractile Nanomachines.

  2017cites this paper
• Tn6350, a Novel Transposon Carrying Pyocin S8 Genes Encoding a Bacteriocin with Activity against Carbapenemase-Producing Pseudomonas aeruginosa

  2017cites this paper
• Phage Tail-Like Bacteriocins.

  2017cites this paper
• Infection therapy: the problem of drug resistance – and possible solutions

  2017cites this paper
• The therapeutic potential of bacteriocins as protein antibiotics

  2017cites this paper
• Conditionally Redundant Bacteriocin Targeting by Pseudomonas syringae

  2017cites this paper
• New class of precision antimicrobials redefines role of Clostridium difficile S-layer in virulence and viability

  2017cites this paper
• Development of an Assay for the Identification of Receptor Binding Proteins from Bacteriophages

  2016cites this paper
• Therapeutics and Vaccines Against Pathogenic Escherichia coli

  2016cites this paper
• Should Phage Therapy Be Approved in the U.S.

  2016cites this paper
• Production and purification of pyocin from a soil associated Pseudomonas aeruginosa strain SA 188.

  2015cites this paper
• Type VI secretion system: secretion by a contractile nanomachine

  2015cites this paper
• Atomic structures of a bactericidal contractile nanotube in its pre- and postcontraction states

  2015cites this paper
• Biophysicochemical characterization of Pyocin SA189 produced by Pseudomonas aeruginosa SA189

  2015cites this paper
• Phage Therapy: Eco-Physiological Pharmacology

  2014cites this paper
• Synthetic Biology and Therapies for Infectious Diseases

  2014cites this paper
• Enterohemorrhagic E. coli Infections

  2014cites this paper
• New Therapeutic Developments against Shiga Toxin-Producing Escherichia coli

  2014cites this paper
• Ribosomally encoded antibacterial proteins and peptides from Pseudomonas.

  2014influential citation
• USING e-ANNOTATION TOOLS FOR ELECTRONIC PROOF CORRECTION

  2014cites this paper
• Independent Co-Option of a Tailed Bacteriophage into a Killing Complex in Pseudomonas

  2014cites this paper
• Peptides as the next generation of anti-infectives.

  2013cites this paper
• Genome Sequence of E. coli O104:H4 Leads to Rapid Development of a Targeted Antimicrobial Agent against This Emerging Pathogen

  2012cites this paper
• Shiga toxin 2-induced intestinal pathology in infant rabbits is A-subunit dependent and responsive to the tyrosine kinase and potential ZAK inhibitor imatinib

  2012cites this paper
• Shiga toxin in enterohemorrhagic E.coli: regulation and novel anti-virulence strategies

  2012influential citation
• Novel High-Molecular-Weight, R-Type Bacteriocins of Clostridium difficile

  2012cites this paper
• Accurate Localization of the Mobile Genomic Islands in Pseudomonas putida

  2012cites this paper